Finance

Lists
Why is 2637 down 6,74%?
Dive Deeper
2637:HKG
Fujian Haixi Pharmaceuticals Co Ltd
150,90 HK$
-6,74%
(-10,90) 1D
20 қаз., 16:08:18 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2637...
Open
159,50 HK$
High
161,80 HK$
Low
149,00 HK$
Mkt. cap
11,89 млрд
Avg. vol.
75,73 мың
Volume
354,55 м.
52-wk high
302,40 HK$
52-wk low
97,50 HK$
Shares outstanding
78,71 млн
No. of employees
200
Open
159,50 HK$
High
161,80 HK$
Low
149,00 HK$
Mkt. cap
11,89 млрд
Avg. vol.
75,73 мың
Volume
354,55 м.
52-wk high
302,40 HK$
52-wk low
97,50 HK$
Shares outstanding
78,71 млн
No. of employees
200
News stories
From web sources and news partners
About Fujian Haixi Pharmaceuticals Co Ltd
CEO-
Employees200
Founded2012
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. нау.
2025 ж. мау.
2026 ж. нау.
2026 ж. мау.
Revenue
150,04 млн
150,04 млн
155,81 млн
155,81 млн
Cost of goods sold
20,31 млн
20,31 млн
28,23 млн
28,23 млн
Cost of revenue
20,31 млн
20,31 млн
28,23 млн
28,23 млн
Research and development expenses
13,56 млн
13,56 млн
20,38 млн
20,38 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,69 млн
55,69 млн
55,98 млн
55,98 млн
Operating expense
70,26 млн
70,26 млн
75,50 млн
75,50 млн
Total operating expenses
90,57 млн
90,57 млн
103,73 млн
103,73 млн
Operating income
59,47 млн
59,47 млн
52,07 млн
52,07 млн
Other non operating income
7,63 мың
7,63 мың
-8,03 млн
-8,03 млн
EBT including unusual items
61,44 млн
61,44 млн
42,15 млн
42,15 млн
EBT excluding unusual items
58,72 млн
58,72 млн
46,19 млн
46,19 млн
Income tax expense
7,54 млн
7,54 млн
1,63 млн
1,63 млн
Effective tax rate
12,27%
12,27%
3,86%
3,86%
Other operating expenses
873,16 м.
873,16 м.
-1,33 млн
-1,33 млн
Net income
53,90 млн
53,90 млн
40,52 млн
40,52 млн
Net profit margin
35,93%
35,93%
26,01%
26,01%
Earnings per share
-
-
-
-
Interest and investment income
919,46 м.
919,46 м.
3,96 млн
3,96 млн
Interest expense
-1,67 млн
-1,67 млн
-1,81 млн
-1,81 млн
Net interest expenses
-754,12 м.
-754,12 м.
2,15 млн
2,15 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
60,20 млн
60,20 млн
53,48 млн
53,48 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары